Changing pattern of sputum cell counts during successive exacerbations of airway disease

Respiratory Medicine

Volumn 101, Issue 10, 2007, Pages 2217-2220

  D'silva, Liesel ^a   Cook, Richard J ^a,b   Allen, Christopher J ^a   Hargreave, Frederick E ^a   Parameswaran, Krishnan ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Asthma; COPD; Exacerbations; Inflammation; Sputum cell counts

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIECTASIS; BRONCHITIS; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; EOSINOPHIL COUNT; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RETROSPECTIVE STUDY; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; SPUTUM;

EID: 34548247694     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.05.010     Document Type: Article

References (24)

1. Wedzicha J.A., and Wilkinson T. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers. Proc Am Thorac Soc 3 (2006) 218-221
2. Rodrigo G.J., Rodrigo C., and Hall J.B. Acute asthma in adults: a review. Chest 125 (2004) 1081-1102
3. Jayaram L., Pizzichini M.M., Cook R.J., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 (2006) 483-494
4. Papi A., Bellettato C.M., Braccioni F., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173 (2006) 1114-1121
5. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., and Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19 (2002) 68-75
6. Parameswaran K., Watson R., Gauvreau G.M., Sehmi R., and O'Byrne P.M. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med 169 (2004) 915-920
7. Lemiere C., Romeo P., Chaboillez S., Tremblay C., and Malo J.L. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 110 (2002) 641-646
8. Brightling C.E., Ward R., Wardlaw A.J., and Pavord I.D. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J 15 (2000) 682-686
9. Pizzichini M.M., Pizzichini E., Clelland L., Efthimiadis A., Pavord I., and Dolovich J. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 13 (1999) 15-21
10. Berlyne G.S., Efthimiadis A., Hussack P., Groves D., Dolovich J., and Hargreave F.E. Sputum in asthma: color versus cell counts. J Allergy Clin Immunol 105 (2000) 182-183
11. Leigh R., Pizzichini M.M., Morris M.M., Maltais F., Hargreave F.E., and Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 27 (2006) 964-971
12. Pizzichini E., Pizzichini M.M., Efthimiadis A., Hargreave F.E., and Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J 9 (1996) 1174-1180
13. Lawless J.F., Wigg M.B., Tuli S., et al. Analysis of repeated failures or durations, with application to shunt failures for patients with paediatric hydrocephalus. Appl Stat 50 (2001) 449-465
14. Parameswaran K. Treatment strategy for asthma: one for all and all for one?. Chest 129 (2006) 221-223
15. Parameswaran K., Pizzichini E., Pizzichini M.M., Hussack P., Efthimiadis A., and Hargreave F.E. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J 15 (2000) 486-490
16. Wenzel S.E., Schwartz L.B., Langmack E.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
17. Di Franco A., Bartoli M.L., Carnevali S., et al. Analysis of sputum cell counts during spontaneous moderate exacerbations of asthma in comparison to the stable phase. J Asthma 40 (2003) 155-162
18. Turner M.O., Hussack P., Sears M.R., Dolovich J., and Hargreave F.E. Exacerbations of asthma without sputum eosinophilia. Thorax 50 (1995) 1057-1061
19. Gibson P.G., Norzila M.Z., Fakes K., Simpson J., and Henry R.L. Pattern of airway inflammation and its determinants in children with acute severe asthma. Pediatr Pulmonol 28 (1999) 261-270
20. Mercer P.F., Shute J.K., Bhowmik A., Donaldson G.C., Wedzicha J.A., and Warner J.A. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 6 (2005) 151
21. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 22 (2003) 470-477
22. Pizzichini E., Pizzichini M.M., Efthimiadis A., Hargreave F.E., and Dolovich J. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 154 (1996) 308-317
23. Seemungal T.A., Donaldson G.C., Bhowmik A., Jeffries D.J., and Wedzicha J.A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1608-1613
24. Siva R., Green R.H., Brightling C.E., et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 29 (2007) 906-913